OX40_SCLC_Yokouchi et al.

Mendeley Data2021-03-26 更新2026-04-09 收录

肿瘤免疫生物标志物

小细胞肺癌临床病理

数据链接：

https://data.mendeley.com/datasets/vnjp6g7d3z 数据链接链接失效反馈

官方服务：

资源简介：

Raw data of IHC score with detailed clinical information in individual patients with SCLC

创建时间：

2021-03-26

Next Generation Sequencing (RNAseq) of non-small cell lung cancer

肿瘤免疫生物标志物

癌细胞转录组

Cancer testis antigens (CTAs) are of clinical interest as biomarkers and present valuable targets for immunotherapy. To comprehensively characterize the CTA landscape of non-small cell lung cancer (NS

NIAID Data Ecosystem50

Fig. 1d

肿瘤免疫生物标志物

肿瘤基因表达分析

Percentage of patients with 50% of MICA/B-positive tumor cells on biopsy specimens from primary breast cancer ER+ (n=20), breast cancer ER- (n=15), metastatic melanoma (n=72), HNSCC (n=82), squamous N

NIAID Data Ecosystem50

Heterogenity and pleiotropy analyses for associations between circulating cytokines and CRC.

肿瘤免疫生物标志物

结直肠癌遗传关联分析

Heterogenity and pleiotropy analyses for associations between circulating cytokines and CRC.

Figshare2023-12-14 更新30

DataSheet_1_Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients.docx

化疗疗效预测

肿瘤免疫生物标志物

BackgroundBiomarkers predicting treatment response may be used to stratify patients with pancreatic ductal adenocarcinoma (PDAC) for available therapies. The aim of this study was to evaluate the asso

NIAID Data Ecosystem50

Comparison of PD-L1 expression on TCs by 73–10, SP142, and E1L3N assays in sample ages.

PD-L1检测方法比较

肿瘤免疫生物标志物

Comparison of PD-L1 expression on TCs by 73–10, SP142, and E1L3N assays in sample ages.

NIAID Data Ecosystem40